BeStock  
Stocks › Medical Devices › DXCM

DexCom DXCM

US equityMarket cap rank #671Medical DevicesInternet of Things
$79.32 −$0.87 (-1.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $78.18 -1.44%
Open$80.48
Prev close$80.19
Day range$78.75 – $81.58
Volume4.61M
Market cap$29.58B
P/E (TTM)31.2
Dividend yield–

Earnings

Average move on report day±10.2%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+19.4%
Worst reaction-40.7%

Stock move on the day after each report

+10.1%2023/Q3-5.2%2023/Q4-40.7%2024/Q2-1.9%2024/Q3+5.9%2024/Q4+16.2%2025/Q1-9.3%2025/Q2-14.6%2025/Q3+7.6%2025/Q4+3.0%2026/Q1+12.0%2026/Q2+3.0%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026After Market±9.4%+2.95%Within range
2026/Q230 Jul 2026After Market±9.5%+11.95%Bigger than priced
2026/Q130 Apr 2026After Market±10.8%+3.02%Within range
2025/Q412 Feb 2026After Market±11.6%+7.59%Within range
2025/Q330 Oct 2025After Market±16.0%-14.63%Within range
2025/Q230 Jul 2025After Market±9.8%-9.31%Within range
2025/Q11 May 2025After Market±11.6%+16.17%Bigger than priced
2024/Q413 Feb 2025After Market±10.3%+5.92%Within range
2024/Q324 Oct 2024After Market±13.5%-1.88%Within range
2024/Q225 Jul 2024After Market±12.1%-40.66%Bigger than priced
2023/Q48 Feb 2024After Market±8.3%-5.18%Within range
2023/Q326 Oct 2023After Market±14.7%+10.11%Within range
2023/Q227 Jul 2023After Market±9.6%+2.33%Within range
2023/Q127 Apr 2023After Market±10.2%-1.81%Within range
2022/Q49 Feb 2023After Market±9.9%+9.93%Bigger than priced
2022/Q327 Oct 2022After Market±13.2%+19.38%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.34B+11.2% YoY
Operating profit$327.20M+34.9% YoY
Net profit$275.10M-3.1% YoY
Diluted EPS$0.72+2.9% YoY
Free cash flow$906.20M+2.4% YoY
Operating cash flow$1.12B

Revenue, last 8 quarters

$1.1BDec '24$1.0BMar '25$1.2BJun '25$1.2BSep '25$1.3BDec '25$1.2BMar '26$1.3BJun '26$1.3BSep '26

Net profit, last 8 quarters

$151.7MDec '24$105.4MMar '25$179.8MJun '25$283.8MSep '25$267.3MDec '25$199.5MMar '26$249.1MJun '26$275.1MSep '26

Profitability & balance sheet

Gross margin63.4%
Operating margin24.0%
Net margin19.4%
Return on equity37.7%
Return on assets14.4%
Return on invested capital20.4%
Current ratio1.74
Liabilities / assets59.4%
Cash & investments$1.82B
Total debt$1.37B
Net cash (debt)$445.70M
Free cash flow / sales33.9%

Discussion

No comments yet — be the first to weigh in on DXCM.

Sign in to join the discussion.

Scroll to Top